KOPRANKopranKOPRAN info
$2.52info-0.16%24h
Global rank19138
Market cap$121.71M
Change 7d2.92%
YTD Performance-10.97%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Kopran (KOPRAN) Stock Overview

    Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as topical preparations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is headquartered in Mumbai, India.

    KOPRAN Stock Information

    Symbol
    KOPRAN
    Address
    Parijat HouseMumbai, 400018India
    Founded
    -
    Trading hours
    -
    Website
    https://www.kopran.com
    Country
    🇮🇳 India
    Phone Number
    91 22 4366 1111

    Kopran (KOPRAN) Price Chart

    -
    Value:-

    Kopran Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.52
    N/A
    Market Cap
    $121.71M
    N/A
    Shares Outstanding
    48.21M
    N/A
    Employees
    902.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org